Stephanie B. Wheeler, PhD, MPH (IMAGE)
Caption
“The cost of cancer drugs in the U.S. has rapidly increased, even for generics. As a society, we urgently need more strategies to reduce cancer drug costs without compromising outcomes, and our analysis provides quantifiable evidence to help providers choose lower priced, but equally effective sequences of drugs,” said Stephanie B. Wheeler, PhD, MPH.
Credit
UNC Lineberger Comprehensive Cancer Center
Usage Restrictions
None
License
Original content